These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 26670936)

  • 1. Comparison of Two Parathyroid Hormone Assays in Hemodialysis Patients.
    Donati G; Cianciolo G; Capelli I; Baraldi O; Gambaretto C; Demelas V; Marchetti A; La Manna G
    Artif Organs; 2016 Oct; 40(10):1013-1016. PubMed ID: 26670936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher parathyroid hormone (PTH) concentrations with the Architect PTH assay than with the Elecsys assay in hemodialysis patients, and a simple way to standardize these two methods.
    Monge M; Jean G; Bacri JL; Lemaitre V; Masy E; Joly D; Souberbielle JC
    Clin Chem Lab Med; 2009; 47(3):362-6. PubMed ID: 19199835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switching between parathormone (PTH) assays: the impact on the diagnosis of renal osteodystrophy.
    Bekő G; Butz H; Berta K; Tislér A; Olajos F; Vásárhelyi B; Patócs A
    Clin Chem Lab Med; 2013 Jun; 51(6):1251-6. PubMed ID: 23241601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010.
    Hermsen D; Franzson L; Hoffmann JP; Isaksson A; Kaufman JM; Leary E; Müller C; Nakatsuka K; Nishizawa Y; Reinauer H; Riesen W; Roth HJ; Steinmüller T; Troch T; Bergmann P
    Clin Lab; 2002; 48(3-4):131-41. PubMed ID: 11934215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between a second and a third generation parathyroid hormone assay in hemodialysis patients.
    Gannagé-Yared MH; Farès C; Ibrahim T; Rahal ZA; Elias M; Chelala D
    Metabolism; 2013 Oct; 62(10):1416-22. PubMed ID: 23769129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Elecsys PTH(1-84) assay with four contemporary second generation intact PTH assays and association with other biomarkers in chronic kidney disease patients.
    Tan K; Ong L; Sethi SK; Saw S
    Clin Biochem; 2013 Jun; 46(9):781-6. PubMed ID: 23384535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A
    J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A; Naderi AS
    Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F; Corradi B; Imbasciati E
    Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable parathyroid hormone(1-84)/carboxylterminal PTH ratios detected by 4 novel parathyroid hormone assays.
    Koller H; Zitt E; Staudacher G; Neyer U; Mayer G; Rosenkranz AR
    Clin Nephrol; 2004 May; 61(5):337-43. PubMed ID: 15182128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel electrochemiluminescence immunoassay exclusively for full-length parathyroid hormone during treatment with cinacalcet for secondary hyperparathyroidism.
    Tanaka H; Komaba H; Koizumi M; Kakuta T; Fukagawa M
    Ther Apher Dial; 2011 Jun; 15 Suppl 1():56-61. PubMed ID: 21595854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative measurement of intact parathyroid hormone in renal hyperparathyroidism by an inexpensive routine assay.
    Seehofer D; Rayes N; Ulrich F; Müller C; Lang M; Neuhaus P; Steinmüller T
    Langenbecks Arch Surg; 2001 Nov; 386(6):440-3. PubMed ID: 11735018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid hormone and growth in children with chronic renal failure.
    Waller SC; Ridout D; Cantor T; Rees L
    Kidney Int; 2005 Jun; 67(6):2338-45. PubMed ID: 15882277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of vitamin C on parathyroid hormone in hemodialysis patients with mild to moderate secondary hyperparathyroidism.
    Sanadgol H; Bayani M; Mohammadi M; Bayani B; Mashhadi MA
    Iran J Kidney Dis; 2011 Nov; 5(6):410-5. PubMed ID: 22057074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium, phosphate, and PTH levels in the hemodialysis population: a multicenter study.
    Gallieni M; Cucciniello E; D'Amaro E; Fatuzzo P; Gaggiotti A; Maringhini S; Rotolo U; Brancaccio D;
    J Nephrol; 2002; 15(2):165-70. PubMed ID: 12018633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect Modifying Role of Serum Calcium on Mortality-Predictability of PTH and Alkaline Phosphatase in Hemodialysis Patients: An Investigation Using Data from the Taiwan Renal Registry Data System from 2005 to 2012.
    Lin YC; Lin YC; Hsu CY; Kao CC; Chang FC; Chen TW; Chen HH; Hsu CC; Wu MS;
    PLoS One; 2015; 10(6):e0129737. PubMed ID: 26107510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between whole and intact parathyroid hormone assays.
    Taniguchi M; Tanaka M; Hamano T; Nakanishi S; Fujii H; Kato H; Koiwa F; Ando R; Kimata N; Akiba T; Kono T; Yokoyama K; Shigematsu T; Kakuta T; Kazama JJ; Tominaga Y; Fukagawa M
    Ther Apher Dial; 2011 Jun; 15 Suppl 1():42-9. PubMed ID: 21595852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid hormone variability parameters for identifying high turnover osteodystrophy disease in hemodialysis patients: an observational retrospective cohort study.
    De Paola L; Coppolino G; Bolignano D; Buemi M; Lombardi L
    Ther Apher Dial; 2010 Dec; 14(6):566-71. PubMed ID: 21118364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A lower proportion of circulating active parathyroid hormone in peritoneal dialysis does not allow the pth inter-method adjustment proposed for haemodialysis.
    González-Casaus ML; González-Parra E; Sánchez-González C; Albalate M; de la Piedra-Gordo C; Fernández E; Torregrosa V; Rodríguez M; Lorenzo V
    Nefrologia; 2014 May; 34(3):330-40. PubMed ID: 24798561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.